These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38336502)

  • 21. Associations of AD Biomarkers and Cognitive Performance with Nutritional Status: The NUDAD Project.
    Doorduijn AS; Visser M; van de Rest O; Kester MI; de Leeuw FA; Boesveldt S; Fieldhouse JLP; van den Heuvel EGHM; Teunissen CE; Scheltens P; van der Flier WM; de van der Schueren MAE
    Nutrients; 2019 May; 11(5):. PubMed ID: 31126170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of Life in relation to neuropsychiatric symptoms in Alzheimer's disease: 5-year prospective ALSOVA cohort study.
    Hongisto K; Hallikainen I; Selander T; Törmälehto S; Väätäinen S; Martikainen J; Välimäki T; Hartikainen S; Suhonen J; Koivisto AM
    Int J Geriatr Psychiatry; 2018 Jan; 33(1):47-57. PubMed ID: 28067961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropsychiatric Symptoms and Risk of Progression to Alzheimer's Disease Among Mild Cognitive Impairment Subjects.
    Dietlin S; Soto M; Kiyasova V; Pueyo M; de Mauleon A; Delrieu J; Ousset PJ; Vellas B
    J Alzheimers Dis; 2019; 70(1):25-34. PubMed ID: 31127783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular risk factors and neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study.
    Steinberg M; Hess K; Corcoran C; Mielke MM; Norton M; Breitner J; Green R; Leoutsakos J; Welsh-Bohmer K; Lyketsos C; Tschanz J
    Int J Geriatr Psychiatry; 2014 Feb; 29(2):153-9. PubMed ID: 23681754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Cerebral Small Vessel Disease Burden with Neuropsychiatric Symptoms in Non-Demented Elderly: A Longitudinal Study.
    Cao QL; Sun Y; Hu H; Wang ZT; Tan L; Yu JT;
    J Alzheimers Dis; 2022; 89(2):583-592. PubMed ID: 35912738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropsychiatric symptoms and functional status in Alzheimer's disease and vascular dementia patients.
    D'Onofrio G; Sancarlo D; Panza F; Copetti M; Cascavilla L; Paris F; Seripa D; Matera MG; Solfrizzi V; Pellegrini F; Pilotto A
    Curr Alzheimer Res; 2012 Jul; 9(6):759-71. PubMed ID: 22715983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The severity of neuropsychiatric symptoms is higher in early-onset than late-onset Alzheimer's disease.
    Falgàs N; Allen IE; Spina S; Grant H; Piña Escudero SD; Merrilees J; Gearhart R; Rosen HJ; Kramer JH; Seeley WW; Neylan TC; Miller BL; Rabinovici GD; Grinberg LT; Walsh CM
    Eur J Neurol; 2022 Apr; 29(4):957-967. PubMed ID: 34862834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease.
    Siafarikas N; Selbaek G; Fladby T; Šaltytė Benth J; Auning E; Aarsland D
    Int Psychogeriatr; 2018 Jan; 30(1):103-113. PubMed ID: 28927477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer's disease and cognitively unimpaired individuals.
    Ng KP; Chiew H; Rosa-Neto P; Kandiah N; Ismail Z; Gauthier S
    Transl Neurodegener; 2021 Mar; 10(1):11. PubMed ID: 33789730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Affective symptoms and regional cerebral tau burden in early-stage Alzheimer's disease.
    Tommasi NS; Gonzalez C; Briggs D; Properzi MJ; Gatchel JR; Marshall GA;
    Int J Geriatr Psychiatry; 2021 Jul; 36(7):1050-1058. PubMed ID: 33682933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropsychiatric Symptoms and Functional Decline in Alzheimer's Disease and Lewy Body Dementia.
    Borda MG; Aarsland D; Tovar-Rios DA; Giil LM; Ballard C; Gonzalez MC; Brønnick K; Alves G; Oppedal K; Soennesyn H; Vik-Mo AO
    J Am Geriatr Soc; 2020 Oct; 68(10):2257-2263. PubMed ID: 32738062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropsychiatric symptoms in at-risk groups for AD dementia and their association with worry and AD biomarkers-results from the DELCODE study.
    Sannemann L; Schild AK; Altenstein S; Bartels C; Brosseron F; Buerger K; Cosma NC; Fliessbach K; Freiesleben SD; Glanz W; Heneka MT; Janowitz D; Kilimann I; Kobeleva X; Laske C; Metzger CD; Munk MHJ; Perneczky R; Peters O; Polcher A; Priller J; Rauchmann B; Rösch C; Rudolph J; Schneider A; Spottke A; Spruth EJ; Teipel S; Vukovich R; Wagner M; Wiltfang J; Wolfsgruber S; Duezel E; Jessen F;
    Alzheimers Res Ther; 2020 Oct; 12(1):131. PubMed ID: 33066827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between neuropsychiatric symptoms and Alzheimer's disease pathology: An in vivo positron emission tomography study.
    Yasuno F; Minami H; Hattori H;
    Int J Geriatr Psychiatry; 2021 Apr; 36(4):598-605. PubMed ID: 33165946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment, cerebrovascular disease and Parkinson disease: A cross sectional and longitudinal study.
    Rashidi-Ranjbar N; Churchill NW; Black SE; Kumar S; Tartaglia MC; Freedman M; Lang A; Steeves TDL; Swartz RH; Saposnik G; Sahlas D; McLaughlin P; Symons S; Strother S; Pollock BG; Rajji TK; Ozzoude M; Tan B; Arnott SR; Bartha R; Borrie M; Masellis M; Pasternak SH; Frank A; Seitz D; Ismail Z; Tang-Wai DF; Casaubon LK; Mandzia J; Jog M; Scott CJM; Dowlatshahi D; Hassan A; Grimes D; Marras C; Zamyadi M; Munoz DG; Ramirez J; Berezuk C; Holmes M; Fischer CE; Schweizer TA
    Int J Geriatr Psychiatry; 2024 Mar; 39(3):e6074. PubMed ID: 38491809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood plasma protein profiles of neuropsychiatric symptoms and related cognitive decline in older people.
    Rabl M; Clark C; Dayon L; Bowman GL; Popp J
    J Neurochem; 2023 Jan; 164(2):242-254. PubMed ID: 36281546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between nutritional status and gait performance in Alzheimer's disease.
    He M; Lian T; Guo P; Zhang Y; Huang Y; Qi J; Li J; Guan H; Luo D; Liu Z; Zhang W; Zheng Z; Yue H; Li J; Zhang W; Wang R; Zhang F; Wang X; Zhang W
    CNS Neurosci Ther; 2024 Apr; 30(4):e14502. PubMed ID: 37950363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Longitudinal Assessment of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Alzheimer's Disease and Their Association With White Matter Hyperintensities in the National Alzheimer's Coordinating Center's Uniform Data Set.
    Anor CJ; Dadar M; Collins DL; Tartaglia MC
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jan; 6(1):70-78. PubMed ID: 32389747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropsychiatric symptoms in cognitively normal older persons, and the association with Alzheimer's and non-Alzheimer's dementia.
    Liew TM
    Alzheimers Res Ther; 2020 Mar; 12(1):35. PubMed ID: 32234066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropsychiatric Symptoms and In Vivo Alzheimer's Biomarkers in Mild Cognitive Impairment.
    Spampinato MV; Ulber JL; Fayyaz H; Sullivan A; Collins HR;
    J Alzheimers Dis; 2023; 96(4):1827-1836. PubMed ID: 38007644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific Neuropsychiatric Symptoms Are Associated with Faster Progression in Alzheimer's Disease: Results of the Prospective Dementia Registry (PRODEM-Austria).
    Defrancesco M; Marksteiner J; Kemmler G; Dal-Bianco P; Ransmayr G; Benke T; Mosbacher J; Höller Y; Schmidt R
    J Alzheimers Dis; 2020; 73(1):125-133. PubMed ID: 31744004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.